Board Meetings for ADVENZYMES
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| ADVENZYMES | Advanced Enzyme Technologies Limited | 09 May 2026 | Board Meeting Intimation | Advanced Enzyme Technologies Limited has informed the Exchange about Board Meeting to be held on 09-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend. | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 09 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 31 Jan 2026 | Board Meeting Intimation | Advanced Enzyme Technologies Limited has informed the Exchange about Board Meeting to be held on 31-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 31 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 12 Nov 2025 | Board Meeting Intimation | Advanced Enzyme Technologies Limited has informed the Exchange about Board Meeting to be held on 12-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 . | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 12 Nov 2025 | Financial Results | This is to inform that the Meeting of Board of Directors of the Company is scheduled to be held on Wednesday, November 12, 2025, inter alia, to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2025 | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 02 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 02 Aug 2025 | Board Meeting Intimation | ADVANCED ENZYME TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 02-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 . | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 13 May 2025 | Board Meeting Intimation | ADVANCED ENZYME TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 13-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend. | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 13 May 2025 | Financial Results/Dividend | Intimation of Board Meeting, Record date for interim dividend, if declared by the Board andclosure of Trading Window | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 08 Feb 2025 | Board Meeting Intimation | ADVANCED ENZYME TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 08-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 08 Feb 2025 | Financial Results | To consider and approve the financial results for the period ended December 31, 2024 | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 09 Nov 2024 | Financial Results | To consider and approve the financial results for the period ended September 30, 2024 | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 09 Nov 2024 | Board Meeting Intimation | ADVANCED ENZYME TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . | |
| ADVENZYMES | Advanced Enzyme Technologies Limited | 10 Aug 2024 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
Showing page 1 of 4 (58 total items)